Skip to main content
. 2016 Nov 16;2016(11):CD009178. doi: 10.1002/14651858.CD009178.pub3

NCT00814502.

Methods RCT
Participants AD or vascular dementia, aged 60 to 99 years
Interventions Zolpidem CR, or placebo
Outcomes Primary: sleep efficiency and other actigraphy‐derived sleep parameters
Notes Unclear what proportion of participants have AD. May not have been selected for sleep problem at baseline